Washington State Sells Over $100 Million Worth of Legal Marijuana in July, Bringing in Over $37 Million in Taxes

There was over $100 million worth of legal marijuana sold throughout Washington State in July.

(Photo credit: Vista).

According to data compiled and released by the Washington State Liquor and Cannabis Commission, there was approximately $103 million in legal marijuana sales in July. This is a slight increase from the $100.2 million sold in the previous month, but a slight decrease from the $106 million sold last July. June 2022 retains the monthly high of $109 million.

The yearly total for marijuana sales is now above $700 million, resulting in over $200 million worth of tax revenue. In 2023 there was $1.25 billion in marijuana sales resulting in over $400 million in taxes.
Continue reading

Study: “Psilocybin Appears as a Valuable Treatment for OCD”

A recent study published in Pharmacological Reports by researchers at the Medical University of Warsaw suggests that psilocybin may offer significant benefits in treating obsessive-compulsive disorder (OCD).

Dried psilocybin mushrooms.

OCD is a chronic mental health condition that affects approximately 2% of the population, characterized by persistent and intrusive thoughts (obsessions) and repetitive behaviors (compulsions) that can severely disrupt daily life.

Current pharmacological treatments for OCD primarily target serotonin, dopamine, and glutamate neurotransmission systems. Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed, yet up to 40% of patients do not respond adequately to these treatments. This has created a critical need for new therapeutic options.
Continue reading

UC San Diego Seeking Participants for Five Marijuana Clinical Trials

The University of California, San Diego (UCSD) is currently seeking participants for five clinical trials focused on marijuana and its potential therapeutic benefits.

These studies are part of the university’s ongoing efforts to explore the medical applications of marijuana, which is becoming increasingly relevant as more states legalize its use for both recreational and medicinal purposes, and as marijuana is rescheduled at the federal level.

The first trial investigates the neural mechanisms behind marijuana-induced pain relief. Pain is often referred to as a “silent epidemic,” affecting over 100 million Americans and costing society more than $500 billion annually. This study aims to identify how vaporized marijuana alleviates acute pain by mapping the brain’s response, potentially leading to more effective and targeted pain therapies.
Continue reading

Trump Says He “Agrees a Lot More” with Marijuana Legalization as More States Legalize

Former President Donald Trump, the current Republican nominee for president, is beginning to “agree a lot more” that marijuana should be legalized.

Donald Trump speaking at a press conference at Mar-a-Lago.

“As we legalize it, I start to agree a lot more because, you know, it’s being legalized all over the country,” said Trump at a press conference held today. “Florida has something coming up. I’ll be making a statement about that fairly soon.”

Trump’s comments were made in response to a reporter questioning him on the Biden Administration’s move to reschedule marijuana, and Vice President Harris’ stance that no one should be jailed for marijuana.
Continue reading

Study of Nearly 10 Million People Finds Marijuana Linked to Improved Outcomes for Heart Attack Patients, Reduced In-Hospital Mortality

According to a study published in the Archives of Medical Sciences: Atherosclerotic Disease, heart attack patients with a history of marijuana use have a lower in-hospital mortality rate compared to those without a history of use.

For the study, researchers from various institutions, including the Detroit Medical Center-Wayne State University and the Royal Devon University Healthcare NHS Foundation Trust, conducted a comprehensive analysis of 20 years of hospital data, including data from 9,930,007 acute myocardial infarction (AMI) patients recorded in the National Inpatient Sample (NIS) from 2001 to 2020. Of these, 117,641 patients (1.2%) reported using cannabis. The researchers applied a series of statistical tests and multivariate regression models to compare the outcomes of cannabis users with those who did not use the substance.

“Cannabis users had lower odds of atrial fibrillation, ventricular fibrillation, cardiogenic shock, acute ischaemic stroke, cardiac arrest” and they had a 36% lower risk of all-cause mortality during their hospital stay, state the study’s researchers.
Continue reading

Maine: July Breaks Monthly Marijuana Sales Record With $22.8 Million Spent Across 424,941 Transactions

Marijuana sales in Maine reached a new monthly record in July, with a total of $22,861,337 in sales across 424,941 transactions.

This surpasses the previous month’s total and sets a new benchmark for the state’s cannabis industry, topping the previous record of $21.7 million sold in August 2023.

According to the Maine Office of Cannabis Policy, the average price per gram of dried marijuana in July was $7.20, a decrease of $0.05 from June’s average, and $0.02 higher than the all-time low of $7.18 set in April of this year.
Continue reading

July is a Record-Breaking Month for Marijuana Sales in Montana

In July, there was more legal marijuana sold in Montana than any previous month.

There was $28,717,104 worth of marijuana sold legally July, according to data compiled and released by the Montana Department of Revenue. This breaks the single-month record of $28,697,312 set in August 2023.

$24,899,839 of the total marijuana sales in July were purchased by recreational consumers, with $3,817,266 purchased by medical marijuana dispensaries.
Continue reading

Study: THC May Mitigate High-Fructose Diet Damage in Small Intestine

According to a new study being published in the upcoming issue of the journal Histochemistry and Cell Biology, researchers have found that THC may counteract the damaging effects of a high-fructose diet on the small intestine.

A blackboard with the chemical formula of THC.

The study, available online ahead of print on the website for the US National Library of Medicine, was conducted by researchers from Istanbul University-Cerrahpaşa and Demiroglu Bilim University in Turkey, and the Otto-Von-Guericke-Universität Magdeburg in Germany.

“The consumption of fructose is increasing day by day. Understanding the impact of increasing fructose consumption on the small intestine is crucial since the small intestine processes fructose into glucose”, states the study’s abstract. “∆9-Tetrahydrocannabinol (THC), a key cannabinoid, interacts with CB1 and CB2 receptors in the gastrointestinal tract, potentially mitigating inflammation.”
Continue reading

Federal Legislation to Deschedule Marijuana and Respect States’ Rights Sponsored by Lawmakers From 33 States

Lawmakers from 33 different states are now sponsoring federal legislation to deschedule marijuana, and to respect state marijuana laws.

(Photo credit: Richard Vogel/Associated Press).

The Marijuana Opportunity Reinvestment and Expungement (MORE) Act, filed in April 2023 in the US House of Representatives, now has 94 sponsors, while the Senate’s Cannabis Administration and Opportunity Act (CAOA) has 18 sponsors.

The MORE Act and CAOA would both fully deschedule marijuana, effectively ending its nationwide prohibition. Additionally, both measures propose a federal excise tax on legal marijuana sales and allow for the expungement of prior marijuana convictions.
Continue reading

Massachusetts Voters Have Opportunity to Legalize Psychedelics via Question 4 This November

With the election less than three months away, it won’t be long before Massachusetts voters will have the opportunity to make their state just the third to legalize certain psychedelics such as psilocybin.

Question 4, put forth by the nonprofit Massachusetts for Mental Health Options (MMHO), would legalize the possession and personal cultivation of up to one gram of DMT, 18 grams of non-peyote mescaline, 30 grams of Ibogaine, one gram of psilocybin, and one gram of psilocin. Possessing up to twice this amount would be punishable by a fine of up to $100.

The initiative aims to “expand mental health treatment options in Massachusetts by providing new pathways to access natural psychedelic medicine therapy,” including “creating access to natural psychedelic medicine therapy and removing criminal penalties for personal possession of these medicines.”
Continue reading